Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05483855 · ClinicalTrials.gov registry record

Telehealth-delivered HealthcaRe to ImproVe Care

A clinical trial of Telemedicine, sponsored by Attune Health Research.

Recruiting
Registry status
1,580
Enrollment target
1
Study location

NCT05483855 is a study of Telemedicine that is actively recruiting participants, run by Attune Health Research. The registered enrollment target is 1,580 participants, below the 3,969-participant average among 18 other Telemedicine trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05483855, a study of Telemedicine, is actively recruiting participants, sponsored by Attune Health Research.

RECRUITING
Registry status
1,580 participants
Enrollment target
1
Study location

Study Summary

Objective 1: Evaluate patients' satisfaction with their telehealth care and determine factors associated with satisfaction. Objective 2: Deploy PROs and patient self-assessment tools, specifically a patient-facing instructional in-app tool that instructs RA patients how to perform self-assessment examinations to observe and report the number of tender and swollen joint counts.

Conditions Studied

Interventions

  • OTHER Objective 1 Only: Telehealth Satisfaction Survey
  • OTHER Objective 2 Only: ArthritisPower Joint Assessment

Study Locations (1)

California

  • Attune Health Research Inc - Beverly Hills

Trial Details

FieldValue
Enrollment Target 1,580 participants
Start Date 2023-01-03
Est. Completion 2025-04

Sponsor

Attune Health Research

2 total trials

What the Registry Record Tells You About NCT05483855

The ClinicalTrials.gov registry entry for NCT05483855 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,580 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,969-participant average among 18 other Telemedicine trials with a reported enrollment target (60% lower). The listed sponsor is Attune Health Research, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Telemedicine appearing as the primary indexed condition, and to 2 interventions - of which Objective 1 Only: Telehealth Satisfaction Survey is the first listed.

NCT05483855 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05483855 about?

NCT05483855 is a clinical study titled "Telehealth-delivered HealthcaRe to ImproVe Care". Objective 1: Evaluate patients' satisfaction with their telehealth care and determine factors associated with satisfaction. Objective 2: Deploy PROs and patient self-assessment tools, specifically a patient-facing instructional in-app tool that instructs RA patients how to perform self-assessment...

What is the current status of trial NCT05483855?

This trial is currently recruiting. The enrollment target is 1,580 participants. The study started on 2023-01-03. Estimated completion is 2025-04.

What conditions does trial NCT05483855 study?

This clinical trial studies the following conditions: Telemedicine.

What interventions are being tested in trial NCT05483855?

The interventions under investigation include: Objective 1 Only: Telehealth Satisfaction Survey (OTHER), Objective 2 Only: ArthritisPower Joint Assessment (OTHER).

Who is sponsoring clinical trial NCT05483855?

This trial is sponsored by Attune Health Research, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05483855 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Telemedicine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.